BIOMEDevice Forum is the nation’s premier executive-level conference focusing on convergence and cross-sector collaborations among companies in the biotechnology, medical device, IVD, and pharmaceutical industries. This two day event brings together key players involved in investing, partnering, licensing, and developing business opportunities in the rapidly growing market for innovative healthcare products.
For registration and more detailed information regarding this event go to:
http://www.devicelink.com/expo/bioforum08/index.html
Who Should Attend
Executives at biotechnology, medical device, and pharmaceutical companies with responsibility for corporate management or business development; R&D executives from mature and emerging life sciences firms; investors in medical technology ventures, including angel investors, venture capitalists, and investment bankers; and industry analysts.
About the Producers
MX magazine tackles the business and policy issues that are most critical to today’s medical technology executives. Published bimonthly, the publication reaches 15,000 senior medical technology executives and financial analysts that track the medtech industry.
R&D Directions provides insight into pharmaceutical research and development, from discovery through clinical trials and submission. Leaving the hard science to other publications, R&D Directions focuses on pharmaceutical companies’ R&D business strategies and decisions. Editorial content covers drugs, therapeutic categories, industry segments, and strategies, and imparts extensive intelligence on products in the pipeline. Although R&D Directions contains a wealth of medical and scientific information, it is written in a non-clinical, non-technical style.
BayBio serves the life science industry in Northern California, through offices and representatives in South San Francisco, Berkeley and Sacramento, and through coalition partners in Washington, DC. The association supports the regional bioscience community through advocacy, enterprise support, and the enhancement of research collaboration. Its more than 300 member companies include organizations engaged in, or supportive of, research, development and commercialization of life science technologies.
